✦ LIBER ✦

Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients

✍ Scribed by Herve Tilly; Sylvie Castaigne; Dominique Bordessoule; Francois Sigaux; Marie-thérèse Daniel; Mathieu Monconduit; Pr. Laurent Degos

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 347 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850415)55:8<1633::aid-cncr2820550803>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cytosine arabinoside for acute

High-dose cytosine arabinoside for acute nonlymphocytic leukemia

✍ Dr. Guy Cantin; James K. Brennan 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 1 views

Low-dose cytosine arabinoside for treati

Low-dose cytosine arabinoside for treating hypocellular acute leukemia in the elderly

✍ Heiwa Kanamori; Dr. Atsuo Maruta; Hiroko Miyashita; Hiroshi Harano; Hitoshi Fuka 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

Treatment of “poor risk” acute nonlympho

Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside

✍ Dr. Edward P. Balaban; John V. Cox; Nancy R. Schneider; Cheryl A. Harth; Barbara 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 1 views

Low-dose cytosine arabinoside in acute n

Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia

✍ Lalit Kumar; V. Kochupillai; Harsch Dua 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 1 views

Low-dose cytosine arabinoside as an alte

Low-dose cytosine arabinoside as an alternative treatment for acute leukemia in Jehovah's Witnesses

✍ Paul M. Dainer; Charles L. Knupp; George P. Sartiano 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Low-dose cytosine arabinoside in the mye

Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia

✍ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre